The Global Fund is working to increase access to all the needed WHO-recommended antiretroviral medicines and formulations at the optimum price while simultaneously maintaining a sustainable competitive market. We have entered into framework agreements with a number of manufacturers to ensure prices and availability, based on anticipated market demand.
The Global Fund's Market Shaping Strategy was approved by the Board in May 2011 and directs the Global Fund to "secure the pediatric ARV market" by adopting a coordinated approach to the procurement of pediatric ARVs in the fight against HIV/AIDS.
The Pediatric ARV Procurement Working Group was established in September 2011 and is comprised of diverse partners and stakeholders, organized into two inter-linked groups: the Pediatric ARV Procurement Working Group and the Procurement Consortium. Since 2016, this group has evolved its scope to include ARVs for adolescents and adults.
The ARV Procurement Working Group (APWG) is the umbrella group including all stakeholders and partners of various interests and mandates in supporting the collective efforts towards securing the ARV market. The working group is chaired by the Global Fund and includes:
The working group observers are:
The Procurement Consortium is a sub-set of the working group focusing on the alignment and coordination of procurement operational activities. The consortium aims to achieve the coordinated procurement approach defined and agreed upon by the ARV Procurement Working Group.